A Study of R547 in Patients With Advanced Solid Tumors.
NCT00400296
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
RG547
Sponsor
Hoffmann-La Roche